MEGHAN HANEWALL: Open Payments
NPI 1043926405 · WARRENVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 34 payments from 16 companies in 2025. Trend: 2023 $636 · 2024 $819 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $286 |
| ABBVIE INC. | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Amneal Pharmaceuticals LLC | 2 | $50 |
| Incyte Corporation | 2 | $40 |
| Menarini Silicon Biosystems, Inc. | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Eisai Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Lilly USA, LLC | 1 | $32 |
Products named: LYNPARZA, KEYTRUDA, ELAHERE, ALYMSYS, Cellsearch, LYNOZYFIC, Lenvima, JEMPERLI.
Industry payments across IL — which companies pay providers there.
